Related Experiment Video
Updated: Sep 28, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
A novel SOD1 gene mutation in a Korean family with amyotrophic lateral sclerosis
Nam-Hee Kim1, Hyun-Jung Kim, Manho Kim
1Department of Neurology, College of Medicine, Seoul National University, Seoul, South Korea.
Background:
Superoxide dismutase 1 (SOD1) gene mutations are responsible for approximately 20% of all familial amyotrophic lateral sclerosis (ALS) cases. However, these cases, especially those with SOD1 gene mutations, have not been reported in Korea.
Objectives:
The SOD1 gene in Korean family with ALS was screened for potential mutations and the clinical data was collected.
Materials And Methods:
The clinical histories and neurological findings of the family members were obtained. Genomic DNA was isolated from the leukocytes of whole blood samples and the coding region of the SOD1 gene was analyzed by PCR and sequencing.
Results:
The family with ALS showed a novel missense mutation in the SOD1 gene, which was heterozygous for the mutation, GGC to GTT, causing the substitution of valine for glycine at codon 10 (Gly10Val) in exon 1. Clinically, the patients exhibited early onset and rapid disease progression.
Conclusions:
Familial ALS with a novel Gly10Val mutation in the SOD1 gene showed severe clinical features. The mutation lies in a region involved in a dimer contact in the three-dimensional structure of the SOD1 protein. This study expands the number of ALS-associated SOD1 gene mutations.
Related Concept Videos
Pleiotropy
Parkinson Disease l: Introduction
Single Nucleotide Polymorphisms-SNPs
Alzheimer Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Mutations

